Suppression of the lipid-transport activity of OSBPL11 weakens the cytotoxicity of SAC-activating drugs by promoting mitotic slippage
Biochemical and Biophysical Research Communications · 2026
DOI: 10.1016/j.bbrc.2025.153045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2026. Verfasst von Ayaka Kawaji und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biochemistry and Molecular Biology, Kyoto Pharmaceutical University, Kyoto, 607-8414, Japan. Hauptthemen laut MEDLINE: Mitosis, M Phase Cell Cycle Checkpoints, Receptors, Steroid, Antineoplastic Agents. Die Arbeit nennt 25 Literaturangaben. Gefördert von: Takeda Science Foundation, Takahashi Industrial and Economic Research Foundation, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Sustained activation of the spindle assembly checkpoint (SAC) arrests cells in mitosis, resulting in mitotic cell death; therefore, SAC-activating drugs have been developed and clinically used as anti-cancer agents. However, some mitotic cells exhibit mitotic slippage, an event of mitotic exit without SAC satisfaction, and less sensitivity to these drugs. For developing efficient anti-cancer therapy, it is required to reveal the mechanism underlying the cell fate determination between cell death and mitotic slippage. In this study, we found that oxysterol-binding protein-like 11 (OSBPL11) is important for cell fate determination during mitotic arrest. OSBPL11 knockdown accelerates mitotic slippage and instead represses cell death during mitotic arrest by treatment with the Eg5 inhibitor S-trityl-l-cysteine (STLC), although the duration from mitotic entry to slippage or death is not altered. OSBPL11 knockdown exhibits a similar phenotype in paclitaxel-treated cells. Cyclin B1 levels are decreased in OSBPL11-knockdown mitotic cells. Treatment with the APC/C inhibitor proTAME mitigates both the decrease in the cyclin B1 levels and the acceleration of mitotic slippage caused by OSBPL11 knockdown. Although the OSBPL11 wild type could mitigate the acceleration of mitotic slippage and the repression of cell death induced by OSBPL11 knockdown, mutants lacking the lipid transport and lipid binding activities could not. Furthermore, OSBPL11 knockdown promotes survival upon STLC and paclitaxel treatments. These results suggest that OSBPL11 represses mitotic slippage and accelerates cell death during mitotic arrest in a manner dependent on both lipid transport and lipid binding activities, promoting the cytotoxic effect of SAC-activating drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Biochemistry and Molecular Biology, Kyoto Pharmaceutical University, Kyoto, 607-8414, Japan.
- Laboratory of Biochemistry and Molecular Biology, Kyoto Pharmaceutical University, Kyoto, 607-8414, Japan. Electronic address: yuki2019@mb.kyoto-phu.ac.jp.
Förderung
- Takeda Science Foundation
- Takahashi Industrial and Economic Research Foundation
- Japan Society for the Promotion of Science
Zitieren
APA
Kawaji, A., Yuki, R., Saito, Y., & Nakayama, Y. (2026). Suppression of the lipid-transport activity of OSBPL11 weakens the cytotoxicity of SAC-activating drugs by promoting mitotic slippage. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2025.153045
Vancouver
Kawaji A, Yuki R, Saito Y, Nakayama Y. Suppression of the lipid-transport activity of OSBPL11 weakens the cytotoxicity of SAC-activating drugs by promoting mitotic slippage. Biochemical and Biophysical Research Communications. 2026. doi:10.1016/j.bbrc.2025.153045
BibTeX
@article{Kawaji2026,
author = {Kawaji, Ayaka and Yuki, Ryuzaburo and Saito, Youhei and Nakayama, Yuji},
title = {Suppression of the lipid-transport activity of OSBPL11 weakens the cytotoxicity of SAC-activating drugs by promoting mitotic slippage},
journal = {Biochemical and Biophysical Research Communications},
year = {2026},
doi = {10.1016/j.bbrc.2025.153045}
}
EUVIMED